Abstract:Nonalcoholic fatty liver disease (NAFLD) is associated with obesity, insulin resistance, and type 2 diabetes. NAFLD represents a large spectrum of diseases ranging from (1) fatty liver (hepatic steatosis); (2) steatosis with inflammation and necrosis; to (3) cirrhosis. The animal models to study NAFLD/nonalcoholic steatohepatitis (NASH) are extremely useful, as there are still many events to be elucidated in the pathology of NASH. The study of the established animal models has provided many clues in the pathogenesis of steatosis and steatohepatitis, but these remain incompletely understood. The different mouse models can be classified in two large groups. The first one includes genetically modified (transgenic or knockout) mice that spontaneously develop liver disease, and the second one includes mice that acquire the disease after dietary or pharmacological manipulation. Although the molecular mechanism leading to the development of hepatic steatosis in the pathogenesis of NAFLD is complex, genetically modified animal models may be a key for the treatment of NAFLD. Ideal animal models for NASH should closely resemble the pathological characteristics observed in humans. To date, no single animal model has encompassed the full spectrum of human disease progression, but they can imitate particular characteristics of human disease. Therefore, it is important that the researchers choose the appropriate animal model. This review discusses various genetically modified animal models developed and used in research on NAFLD.

Research advances in animal models of nonalcoholic fatty liver disease

Pathogenesis of and Major Animal Models Used for Nonalcoholic Fatty Liver Disease

[Research Advances in Diagnosis of Non-Alcoholic Fatty Liver Disease].

Comparison of Animal Models for the Study of Nonalcoholic Fatty Liver Disease

Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research

Rodent Models of Nonalcoholic Fatty Liver Disease

Research Progress on the Mechanism of Traditional Chinese Medicine in the Treatment of Non-Alcoholic Fatty Liver Disease Based on Oxidative Stress

Mouse Models of Nonalcoholic Fatty Liver Disease (NAFLD): Pathomechanisms and Pharmacotherapies

Recent Progress of Proteomics in Nonalcoholic Fatty Liver Disease*

Advances in Studies on Molecular Mechanisms of Nonalcoholic Fatty Liver Disease

Genetically modified mouse models for the study of nonalcoholic fatty liver disease

Shedding light on non-alcoholic fatty liver disease: Pathogenesis, molecular mechanisms, models, and emerging therapeutics

Research Progress on Non-Alcoholic Fatty Liver Disease

Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases

Research advances in non-alcoholic fatty liver disease: a review of current status and prospect

Analysis of Key Factors Affecting on the Drug Development for NAFLD/NASH

Evaluation of Nonalcoholic Steatohepatitis Animal Model from A New Viewpoint

NAFLD-Related HCC: Focus on the Latest Relevant Preclinical Models

Progress in the Study of Animal Models of Metabolic Dysfunction-Associated Steatotic Liver Disease

Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease

Current status of research on nonalcoholic fatty liver disease in China